Editorial: Schizophrenia International Research Society

Por Kane, John M.
Publicado em 2007

In Response to Healy

Por Kane, John M.
Publicado em 2003

Clozapine is underutilized

Por Kane, John M.
Publicado em 2012

The future of pharmacotherapy for schizophrenia

Por KANE, JOHN M, MALHOTRA, ANIL
Publicado em 2003

Cognitive deficits in schizophrenia: short-term and long-term

Por KANE, JOHN M., LENCZ, TODD
Publicado em 2008

Unanswered Questions in Schizophrenia Clinical Trials

Por Kane, John M., Leucht, Stefan
Publicado em 2008

Issues in Psychopharmacology

Por Kane, John M., Leucht, Stefan
Publicado em 2008

Past and Present Progress in the Pharmacologic Treatment of Schizophrenia

Por Kane, John M., Correll, Christoph U.
Publicado em 2010

Pharmacologic treatment of schizophrenia

Por Kane, John M., Correll, Christoph U.
Publicado em 2010

Obesity and Coronary Risk in Patients Treated With Second-Generation Antipsychotics

Por Correll, Christoph U., Kane, John M, Manu, Peter
Publicado em 2010

Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives

Por Correll, Christoph U., Kishimoto, Taishiro, Kane, John M.
Publicado em 2011

Sudden Deaths in Psychiatric Patients

Por Manu, Peter, Kane, John M., Correll, Christoph U.
Publicado em 2011

The Comparative Effectiveness of Long-Acting Injectable vs. Oral Antipsychotic Medications in the Prevention of Relapse: A Case Study in CER in Psychiatry

Por Kane, John M., Kishimoto, Taishiro, Correll, Christoph U.
Publicado em 2013

Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies

Por Kane, John M, Kishimoto, Taishiro, Correll, Christoph U
Publicado em 2013

Methodological Issues in Current Antipsychotic Drug Trials

Por Leucht, Stefan, Heres, Stephan, Hamann, Johannes, Kane, John M.
Publicado em 2008

Partial Adherence to Antipsychotic Medication Impacts the Course of Illness in Patients With Schizophrenia: A Review

Por Masand, Prakash S., Roca, Miquel, Turner, Martin S., Kane, John M.
Publicado em 2009

Quantifying Clinical Relevance in the Treatment of Schizophrenia

Por Correll, Christoph U., Kishimoto, Taishiro, Nielsen, Jimmi, Kane, John M.
Publicado em 2011

Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?

Por Alphs, Larry, Benedetti, Fabrizio, Fleischhacker, W. Wolfgang, Kane, John M.
Publicado em 2012

Does Antipsychotic Polypharmacy Increase the Risk for Metabolic Syndrome?

Por Correll, Christoph U., Frederickson, Anne M., Kane, John M., Manu, Peter
Publicado em 2006

Analyzing mHealth Engagement: Joint Models for Intensively Collected User Engagement Data

Por Scherer, Emily A, Ben-Zeev, Dror, Li, Zhigang, Kane, John M
Publicado no JMIR Mhealth Uhealth (2017)